Andreja Avbersek
Overview
Explore the profile of Andreja Avbersek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
1034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wipperman M, Lin A, Gayvert K, Lahner B, Somersan-Karakaya S, Wu X, et al.
Elife
. 2024 Apr;
13.
PMID: 38686919
Gait is impaired in musculoskeletal conditions, such as knee arthropathy. Gait analysis is used in clinical practice to inform diagnosis and monitor disease progression or intervention response. However, clinical gait...
2.
Rajagopal V, Watanabe K, Mbatchou J, Ayer A, Quon P, Sharma D, et al.
Nat Genet
. 2023 Jun;
55(7):1138-1148.
PMID: 37308787
Human genetic studies of smoking behavior have been thus far largely limited to common variants. Studying rare coding variants has the potential to identify drug targets. We performed an exome-wide...
3.
Wipperman M, Pogoncheff G, Mateo K, Wu X, Chen Y, Levy O, et al.
PLOS Digit Health
. 2023 Feb;
1(6):e0000061.
PMID: 36812552
The Earable device is a behind-the-ear wearable originally developed to measure cognitive function. Since Earable measures electroencephalography (EEG), electromyography (EMG), and electrooculography (EOG), it may also have the potential to...
4.
Birkenbihl C, Ahmad A, Massat N, Raschka T, Avbersek A, Downey P, et al.
Sci Rep
. 2023 Feb;
13(1):2897.
PMID: 36801900
Parkinson's disease (PD) is a highly heterogeneous disease both with respect to arising symptoms and its progression over time. This hampers the design of disease modifying trials for PD as...
5.
Pillas D, Klein A, Gasalla T, Avbersek A, Thompson A, Wright J, et al.
Front Neurol
. 2022 Jul;
13:821570.
PMID: 35865639
Progressive supranuclear palsy (PSP) is a rare, relentlessly progressive, ultimately fatal neurodegenerative brain disease. The objective of this study was to assess the burden of PSP on patients, caregivers, and...
6.
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies
Altmann A, Ryten M, Di Nunzio M, Ravizza T, Tolomeo D, Reynolds R, et al.
Neuropathol Appl Neurobiol
. 2021 Aug;
48(1):e12758.
PMID: 34388852
Aims: The causes of distinct patterns of reduced cortical thickness in the common human epilepsies, detectable on neuroimaging and with important clinical consequences, are unknown. We investigated the underlying mechanisms...
7.
Wolking S, Schulz H, Nies A, McCormack M, Schaeffeler E, Auce P, et al.
Pharmacogenomics
. 2020 Apr;
21(5):325-335.
PMID: 32308125
Pharmacoresistance is a major burden in epilepsy treatment. We aimed to identify genetic biomarkers in response to specific antiepileptic drugs (AEDs) in genetic generalized epilepsies (GGE). We conducted a genome-wide...
8.
Testing association of rare genetic variants with resistance to three common antiseizure medications
Wolking S, Moreau C, Nies A, Schaeffeler E, McCormack M, Auce P, et al.
Epilepsia
. 2020 Mar;
61(4):657-666.
PMID: 32141622
Objective: Drug resistance is a major concern in the treatment of individuals with epilepsy. No genetic markers for resistance to individual antiseizure medication (ASM) have yet been identified. We aimed...
9.
Auvin S, Dozieres-Puyravel B, Avbersek A, Sciberras D, Collier J, Leclercq K, et al.
Ann Clin Transl Neurol
. 2020 Feb;
7(3):343-352.
PMID: 32106360
Objective: Infantile spasm syndrome (ISS) is an epileptic encephalopathy without established treatment after the failure to standard of care based on steroids and vigabatrin. Converging lines of evidence indicating a...
10.
Heavin S, McCormack M, Wolking S, Slattery L, Walley N, Avbersek A, et al.
Epilepsia Open
. 2019 Dec;
4(4):563-571.
PMID: 31819912
Objective: Clinical and genetic predictors of response to antiepileptic drugs (AEDs) are largely unknown. We examined predictors of lacosamide response in a real-world clinical setting. Methods: We tested the association...